Pan-cancer analysis of SETD2 mutation and its association with the efficacy of immunotherapy
Abstract Histone methyltransferase SETD2 plays a critical role in maintaining genomic integrity and stability. Here, we investigated the characteristics of SETD2 somatic mutation in the cancer genome atlas pan-cancer cohort. Our data revealed that, compared with SETD2 nonmutant patients, SETD2 mutan...
Guardado en:
Autores principales: | Mingdong Lu, Bin Zhao, Mengshan Liu, Le Wu, Yingying Li, Yingna Zhai, Xian Shen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ae21fcd0412c44bda93ebc0cd806c6e7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The pan-cancer landscape of crosstalk between epithelial-mesenchymal transition and immune evasion relevant to prognosis and immunotherapy response
por: Guangyu Wang, et al.
Publicado: (2021) -
A genomic mutation signature predicts the clinical outcomes of immunotherapy and characterizes immunophenotypes in gastrointestinal cancer
por: Xi Jiao, et al.
Publicado: (2021) -
Cancer immunology and immunotherapy
por: Xiubao Ren
Publicado: (2021) -
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinoma
por: Amaia Lujambio, et al.
Publicado: (2021) -
Novel emerging biomarkers to immunotherapy in kidney cancer
por: Yasser Ged, et al.
Publicado: (2021)